The active ingredient, semaglutide, is a GLP-1 receptor agonist
Nausea is typically transient and can be minimised through gradual dose titration
It may ease Lyme-related symptoms like pain, fatigue, and brain fog by addressing underlying healing processes rather than just masking symptoms
doi: 10.1016/j.jacc.2023.09.811
Clinical Applications (Experimental/Off-Label) Tendinopathies (Achilles, rotator cuff, patellar tendon), ligament injuries Muscle tears IBD (Crohns, ulcerative colitis) Leaky gut syndrome NSAID-induced gastric injury Post-operative recovery TBI, stroke (early animal evidence) Long COVID GI/neuro symptoms (theoretical) Note: These are off-label, experimental, based largely on animal studies, small human case studies